Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SLCO1B1 encodes a liver-specific member of the organic anion transporter family. Additionally we are shipping SLCO1B1 Antibodies (40) and SLCO1B1 Proteins (3) and many more products for this protein.
SLCO1B1*5 allele variants and patient age predict the likelihood of young women with breast cancer developing chemotherapy-induced amenorrhea.
SLCO1B1 polymorphisms appear to be associated with the development of adverse drug reactions to regorafenib.
Polymorphisms in SLCO1B1 and UGT1A1 (show UGT1A1 ELISA Kits) are associated with several different sorafenib side effects
OATP1A2 (show SLCO1A2 ELISA Kits), OATP1B1, and OATP2B1 (show SLCO2B1 ELISA Kits) can mediate cellular uptake of ochratoxin A, which could aggravate OTA toxicity.
Our results did not indicate a strong association between OATP1B1 or OATP1B3 (show SLCO1B3 ELISA Kits) inhibition and hyperbilirubinemia
Polymorphisms of the SLCO1B1 gene ate used for predicting risk of adverse events when using statins.
Critical amino acid residues in the predicted transmembrane pore influencing transport kinetics of the hepatic drug transporter OATP1B1 have been identified.
Genetic polymorphisms of the UGT1A1 (show UGT1A1 ELISA Kits) promoter, specifically the T-3279G phenobarbital-responsive enhancer module and (TA)7 dinucleotide repeat, as well as the intron and coding region variants of the OATP2, HMOX1 (show HMOX1 ELISA Kits), and BLVRA (show BLVRA ELISA Kits) genes, were significantly higher among the cases than the controls.
SLCO1B1 genotype was not associated with the risk of statin-associated muscle symptoms.
these findings demonstrate an important role for OATP1B1 in the systemic pharmacokinetics of multiple drugs used in the treatment of acute myeloid leukemia (show BCL11A ELISA Kits)
This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function.
, liver-specific organic anion transporter 1
, sodium-independent organic anion-transporting polypeptide 2
, solute carrier family 21 (organic anion transporter), member 6
, solute carrier family 21 member 6
, solute carrier organic anion transporter family member 1B1
, solute carrier organic anion transporter family, member 1B1
, solute carrier organic anion transporter family member 1B1-like